Oral Presentations September 23rd - Rooms 1,2 and 3
Presentation Date Abstract Authors Presenter´s name - Theme Title Code indicated by the author 18498 Thomas Smits; Femke Gresnigt; Thomas Smits Clinical Toxicology/drugs of PERFORMANCE OF AN IMMUNOASSAY Eric Franssen; Milly Attema-de abuse METHOD FOR GAMMA-HYDROXYBUTYRIC Jonge ACID (GHB) IN PATIENTS PRESENTED AT THE EMERGENCY DEPARTMENT, A PROSPECTIVE STUDY
18499 Thomas Smits; Femke Gresnigt; Thomas Smits Clinical Toxicology/drugs of DO WE NEED POINT-OF-CARE TESTING OF Milly Attema-de Jonge; Eric abuse GAMMA-HYDROXYBUTYRIC ACID (GHB) AT Fransse THE EMERGENCY DEPARTMENT?
September 23 18730 Lilian H.J. Richter; Julia Menges; Lea Wagmann Clinical Toxicology/drugs of NEW PSYCHOACTIVE SUBSTANCES: Lea Wagmann; Simon D. Brandt; abuse METABOLIC FATE, ISOZYME-MAPPING, 13:30 - 14:45 Folker Westphal; Veit Flockerzi; AND PLASMA PROTEIN BINDING OF 5-APB- ROOM 1 Markus R. Meyer NBOME, 2C-B-FLY-NB2ETO5CL, AND 2C-B- FLY-NBOME
18985 Annelies Cannaert; Marie Annelies Cannaert Clinical Toxicology/drugs of HIDE AND SEEK: OVERCOMING THE Deventer; Melissa Fogarty; abuse MASKING EFFECT OF OPIOID Amanda L.A. Mohr; Christophe P. ANTAGONISTS IN ACTIVITY-BASED Stove SCREENING TESTS 18740 Souleiman El Balkhi ; Roland Souleiman El Balkhi Clinical Toxicology/drugs of METABOLIC INTERACTIONS BETWEEN Lawson; Franck Saint-Marcoux abuse OXYCODONE, BENZODIAZEPINES OR DESIGNER BENZODIAZEPINES PLAY AN IMPORTANT ROLE IN OXYCODONE INTOXICATIONS 19050 Brenda de Winter F de Velde; MN Brenda de Winter Anti-infective drugs POPULATION PHARMACOKINETICS OF Neely; WM Yamada; BCP Koch; S IMIPENEM IN CRITICALLY ILL PATIENTS: A Harbarth; E von Dach; T van COMPARISON BETWEEN PARAMETRIC AND Gelder; A Huttner; JW Mouton NONPARAMETRIC METHODS
September 23 13:30 - 14:45 ROOM 2 18941 Léonard De Vinci Kanda Kupa; Léonard de Vinci Kanda Anti-infective drugs ASSESSMENT OF MEROPENEM Camila Salinas Guillaux; Edvaldo Kupa PHARMACOKINETICS AT THE EARLIER Vieira de Campos; João Manoel da VERSUS LATE PERIOD SEPTIC SHOCK IN Silva Junior; Amanda Maria Ribas ADULT CRITICALLY BURN PATIENTS BASED Rosa de Oliveira; Elson Mendes ON DRUG SERUM MEASUREMENTS DONE Silva Junior; Gabriela Aparecida IN A REALtime Ferreira ; Thiago Camara Oliveira; Silvia Regina Cavani Jorge Santos; David de Souza Gomez
September 23 19011 Jean-Baptiste FOULQUIER; Fabilen Florian Lemaitre Anti-infective drugs DEVELOPMENT OF A TOOL FOR OFLOXACIN FILY; Marie-Clémence VERDIER; AND LEVOFLOXACIN THERAPEUTIC DRUG 13:30 - 14:45 Matthieu REVEST; Camille TRON; MONITORING IN BONE AND JOINT ROOM 2 Cédric ARVIEUX; Antoine INFECTIONS PETITCOLLIN; Pierre TATTEVIN; Jean-LOUIS POLARD; Denis HUTEN; Eric Bellissant; Bruno LAVIOLLE; Florian LEMAITRE
19014 Paul Ken Leong Chin; Sharon Jane Paul Chin Anti-infective drugs VANCOMYCIN DOSING TARGETING Gardiner; Philip George Drennan; TROUGH CONCENTRATIONS LEADS TO Michael Maze; Michaela Beattie; UNNECESSARILY HIGH DRUG EXPOSURE Daniel Frank Broughton Wright; Stephen Chambers
19100 Miao Yan; Dan Tang; Bai-Li Song; Miao Yan Anti-infective drugs VORICONAZOL THERAPY OPTIMIZATION Min Zhang; Feng Wang; Da-Xiong BASED ON TOTAL BILIRUBIN IN PATIENTS Xiang WITH LIVER DYSFUNCTION
19047 Vikram Suryaprakash Gota; Murari Vikram Suryaprakash Gota TDM in Oncology PRETREATMENT TPMT ACTIVITY AND Gurjar; Hasmukh Jain; Manju ERYTHROCYTE 6-TGN LEVELS ARE Sengar PREDICTORS OF TOXICITY OF 6- MERCAPTOPURINE IN ACUTE LYMPHOBLASTIC LEUKEMIA
September 23 13:30 - 14:45 ROOM 3 18907 Brenda Marisol Del Valle Monge; Brenda Marisol Del Valle TDM in Oncology COMPARISON OF TWO PHARMACOKINETIC Patricia Kleiner; Ulrich Jaehde Monge SOFTWARE TOOLS FOR THERAPEUTIC DRUG MONITORING OF FLUOROURACIL (5- FU)
18263 Lisa Stamp; Peter Chapman; Murray Barclay Pharmacogenetics RELATIONSHIPS BETWEEN ALLOPURINOL Murray Barclay; Anne Horne; Tony DOSE, OXYPURINOL LEVELS AND SERUM Merriman; Daniel Wright; Jill URATE Drake; Nicola Dalbeth
18928 Natalie Espinoza Giacomozzi; Natalie Espinoza Pharmacogenetics FREQUENCY OF THE CYP2C19*17 Carolina Salas Palma; Mauricio Giacomozzi POLYMORPHISM IN A CHILEAN Farfán Urzúa POPULATION AND ITS EFFECT ON September 23 VORICONAZOLE PLASMA CONCENTRATION 13:30 - 14:45 IN IMMUNOCOMPROMISED CHILDREN ROOM 3 18992 Nicolas Picard; Chantal Barin-Le Nicolas Picard Pharmacogenetics A CONSENSUAL PANEL FOR NEXT- Guellec; Séverine Cunat; Tiphaine GENERATION SEQUENCING IN De Beaumais; Alexandre Evrard; PHARMACOGENETICS FROM THE FRENCH Xavier Fonrose; Marie-Claude NATIONAL NETWORK OF Gagnieu; Elodie Gautier; Vincent PHARMACOGENETICS (RNPGX) Haufroid; Fabien Lamoureux; Litaty Mbatchi; Céline Narjoz; Léa Payen; Sylvie Quaranta; Fabienne Thomas; Céline Verstuyft; Marie- Anne Loriot; Jean-Christophe Boyer
18299 Lisa Stamp; Paula Keating; Paul Murray Barclay Other theme RELATIONSHIP BETWEEN ADALIMUMAB Hessian; Murray Barclay; John CONCENTRATIONS, ANTI-DRUG O'Donnell ANTIBODIES AND DISEASE ACTIVITY IN A CROSS SECTION OF RHEUMATOID ARTHRITIS PATIENTS